Search Results 71-80 of 17195 for ulcerative colitis

  1. Evaluation of the Relationship Between Pouch Function and Pouch Inflammation in Patients with Ulcerative Colitis - Mayo Clinic

    Evaluation of the Relationship Between Pouch Function and Pouch Inflammation in Patients with Ulcerative Colitis · Overview · Participation eligibility.

  2. Mayo Clinic Radio: IBD / food allergies / Convergence Science Program

    There are two common types: ulcerative colitis, which causes ulcers, or sores, in the lining of the large intestine and rectum, and Crohn's disease, which ...

  3. Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Ulcerative Colitis - Mayo Clinic

    ... ulcerative colitis (UC). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or ...

  4. The increasing prevalence of inflammatory bowel disease - Mayo Clinic News Network

    William Faubion Jr., a Mayo Clinic gastroenterologist, says inflammatory bowel disease is an umbrella term that covers Crohn's disease and ulcerative colitis, ...

  5. A Study to Evaluate the Safety and Effectiveness of Ustekinumab as Initial or Maintenance Therapy for Patients with Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

    ... Ulcerative Colitis. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More information. Overview.

  6. Research establishes strong association between family history and increased risk of colorectal cancer in patients with inflammatory bowel diseases - Mayo Clinic

    ... colitis, 5,084 (53.5%) were diagnosed with ... ulcerative colitis, with or without concurrent ... IBD are at greater risk of developing CRC than are females with ...

  7. Scott Hennen on Ulcerative Colitis and Mayo Clinic

    ... ulcerative colitis, which was first diagnosed in 1997. Scott had previously described his reasons for being public about his medical condition in this post ...

  8. Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis - Mayo Clinic

    The purpose of this study is to determine whether RPC1063 is effective in the treatment of Ulcerative Colitis (UC). Participation eligibility. Participant ...

  9. A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Participants With Moderate to Severe Ulcerative Colitis (UC) - Mayo Clinic

    A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Participants With Moderate to Severe Ulcerative Colitis (UC) · Overview.

  10. A Study to Evaluate both the Efficacy and Safety Profile of CP-690,550 in Patients with Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

    This study is designed to evaluate the efficacy and safety of tofacitinib (CP-690,550) in patients with moderate to severe ulcerative colitis who have failed or ...